NORML

MAY 26, 2020

Thus, it enables individualization of medical cannabis regimens that can be evaluated pharmacokinetically and pharmacodynamically by accepted pharmaceutical models.” Additional information regarding cannabinoids and pain appears online h ere.

Clinical Trials 252

Clinical Trials Chronic Pain Cannabinoids Patients 252

Cannabis Law Report

DECEMBER 6, 2022

Cannabinoid receptors are currently the most popular targets for CNS in preclinical development, with 391 drugs tagged in total. In 2022, a surge in the pipeline has led […].

Cannabinoids 52

Cannabinoids Pharmaceutical Treatment Law 52

The Cannigma

AUGUST 5, 2022

When antidepressants were first introduced in the mid-20 th century, they were a breakthrough in pharmaceuticals. Of the people who take antidepressants, 30% won’t respond to treatment. But what other options do people suffering from depression, particularly treatment-resistant depression, have? What is ketamine treatment?

Treatment 138

Treatment Research and Development Therapy Digestion 138

Veriheal

APRIL 11, 2022

The final goal is to introduce medicinal cannabis products to the pharmaceutical drug market. This means that the medical and scientific communities can now celebrate broader access to research for the production of pharmaceutical products that are safer than smokable or vaporizable cannabis. Drug Enforcement Agency (DEA). Absolutely.”

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

JANUARY 12, 2021

IRISYS, LLC, a San Diego-based provider of contract pharmaceutical product development and manufacturing services, today announced that it was awarded… Read More.

Treatment 59

Treatment Cannabinoids Pharmaceutical Law 59

FloridaMarijuana.net

AUGUST 15, 2018

Treatment usually aims at reducing reactions and to diminishing the acuity of the reactions. Treatments also seek to increase the subject’s ability to manage trauma-related emotions and to greater confidence in coping abilities. The endocannabinoid system consists of cannabinoid receptors all over the body.

Treatment 182

Treatment Marijuana Research and Development Therapy 182

Cannabis Law Report

DECEMBER 23, 2021

DUBLIN–(BUSINESS WIRE)– “The Pharmaceutical Cannabis Report: 2nd Edition” report has been added to ResearchAndMarkets.com’s offering. This report has been compiled to assist interested parties in understanding the market for the medical use of cannabinoids and where it may be heading. GW Pharmaceuticals.

Pharmaceutical 96

Pharmaceutical Clinical Trials Research and Development Cannabinoids 96

Cannabis Law Report

APRIL 22, 2021

Patent protects Supera-CBD, a preclinical cannabidiol derivative that targets cannabinoid receptor type 2 for the treatment of neuroinflammatory and neurodegenerative… Read More.

Cannabinoids 98

Cannabinoids Pharmaceutical Treatment CBD 98

Kind Meds (Cannabis Education Blog)

SEPTEMBER 1, 2020

One of the biggest areas of contention in the public debate about cannabis legalization is the viability of medicinal cannabis as a treatment for many mental health disorders, such as anxiety, depression, bipolar disorder, schizophrenia, and others. Cannabis Is a Unique Substance and Treatment Method. CBD for Mental Health Treatment.

Treatment 122

Treatment Research and Development CBD THC 122

Cannabis Law Report

JUNE 17, 2021

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) raised its full-year 2021 financial guidance based on the acquisition of GW Pharmaceuticals, which was bought on May 5, 2021. regulatory approval, and our new cannabinoid research platform,” said Renée Galá, the chief financial officer of Jazz Pharmaceuticals.

Pharmaceutical 108

Pharmaceutical Clinical Trials Therapy Programs 108

Cannabis Law Report

JULY 1, 2021

As Curaleaf International ‘s subsidiary Adven GmbH seeks to advance its medical cannabis products in Germany, it has teamed up with an Italian pharmaceutical company, Zambon Spa , with whom it will provide medical cannabis treatments for patients, with an initial focus on neurological therapies.

Treatment 93

Treatment Pharmaceutical Therapy Oil 93

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

In either case, there is definitely a connection, and the widening availability for adults to consume cannabis legally for recreational and medicinal purposes has driven public interest into using cannabis for mental health treatment. Between CBD and THC, CBD seems to hold the best potential as a treatment for anxiety compared to THC.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Veriheal

SEPTEMBER 18, 2020

Conventional forms of treatment are often accompanied by adverse side effects but there is hope for effective treatment with fewer side effects. . million of NWS Health funding for their Cannabinoid Therapeutics and Brain and Mind Centre to see if cannabidiol can be that effective treatment for spinal cord injury.

Treatment 98

Treatment Chronic Pain Research and Development CBD 98

Kind Meds (Cannabis Education Blog)

JANUARY 27, 2022

Since the popularization of CBD in recent years, it’s more common to see cannabis recognized as a true medical treatment. Lately, the cannabinoid CBN (or cannabinol) has been rising in popularity. CBN is a cannabinoid that can be synthesized out of THC. CBN is a cannabinoid that can be synthesized out of THC. What Is CBN?

Cannabinoids 52

Cannabinoids Treatment Extraction THC 52

Veriheal

AUGUST 31, 2020

Most of the conventional methods for treating migraines involve pharmaceutical medication, which has been known to be accompanied by unwanted side effects, especially from opioid based medication. If you have ever suffered through a migraine , you’ll know how much an effective alleviator is necessary. What Does the Study Have to Say?

Treatment 98

Treatment Consumption Indica Hybrid 98

Puff Puff Post

MARCH 10, 2020

SOURCE InMed Pharmaceuticals Inc. ” Study 755-101-HV is a randomized, vehicle controlled, double-blind, Phase 1 trial, examining the safety and tolerability of two strengths of INM-755 cream in 22 healthy adult volunteers over a 14-day treatment period as part of a randomized, vehicle controlled, double-blind, Phase 1 trial.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

Cannabis Law Report

AUGUST 9, 2021

Cannassure Therapeutics Ltd (TASE: CSURE) (“Cannassure”), an Israel based developer and producer of innovative medical cannabis products, announces today that the company was granted a patent for an oral delivery method of cannabis and cannabinoids compositions by the Israel Patents Authority. Of Cannassure.

Cannabinoids 98

Cannabinoids Pharmaceutical Treatment Patients 98

Cannabis Law Report

NOVEMBER 12, 2021

AUSTIN, Texas–(BUSINESS WIRE)– Anebulo Pharmaceuticals, Inc. 11,141,404, titled “Formulations And Methods For Treating Acute Cannabinoid Overdose.” ” The patent provides protection through 2040 and describes use of the Company’s investigational drug ANEB-001 to treat acute cannabinoid overdose.

Pharmaceutical 52

Pharmaceutical Clinical Trials Business Research and Development 52

Peninsula Alternative Health

MAY 15, 2019

Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. However, because cannabinoids reduce seizures through numerous mechanisms of actions, possible drug interactions are still unclear.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Cannabis Info

MARCH 2, 2019

Marijuana as a treatment for epilepsy. Medical cannabis is showing great potential in the treatment of epilepsy. CONVENTIONAL TREATMENT. One of the goals of treating epilepsy is to allow people to continue to live functional and fulfilling life’s epilepsy treatment. CANNABIS AS A POTENTIAL TREATMENT.

Epilepsy 69

Epilepsy Treatment Marijuana Research and Development 69

Cannabis Law Report

SEPTEMBER 28, 2021

Acupuncture is one of the safest alternative forms of treatment for chronic pain. Ideally, it should be used in combination with other therapies, such as herbal medicine and massage, and can be a great addition to other treatments. Radio Frequency Treatment. Acupuncture. First, you need to find a certified acupuncturist.

Treatment 52

Treatment Chronic Pain Therapy Tincture 52

Veriheal

AUGUST 12, 2021

million people across the United States , report experiencing improved quality of life and a more restful night’s sleep after consuming the non-psychoactive cannabinoid CBD (cannabidiol). This, the authors say, “is well below the dose commonly associated with pharmaceutical products (e.g. CBD, which constitutes a $2,770.8

Epilepsy 66

Epilepsy Pharmaceutical Patients Sleep 66

SpeedWeed

AUGUST 8, 2021

It’s the first cannabis-derived pharmaceutical to be legalized in many countries around the world, including the UK, Spain, United States, Canada, and New Zealand. . “It’s not just street cannabis put into a bottle,” GW Pharmaceutical CEO Justin Gover once told the Guardian. View original article.

Cannabinoids 64

Cannabinoids Pharmaceutical DEA Medicine 64

Project CBD

NOVEMBER 11, 2023

In general, I think that botanical medicine is safer than pharmaceutical medicine, that the chances of causing harm are much less. And then cannabis has unique effects for a wide range of conditions, everything from the treatment of pain, treatment of asthma, treatment of immune conditions.

Medicine 301

Medicine Research and Development Pharmaceutical Cannabis 301

WeedAdvisor

JANUARY 8, 2019

For decades, marijuana for cancer treatment seemed out of the question. Even if trials were successful, it is safe to say that using marijuana to treat cancer would meet resistance from the pharmaceutical companies and medical communities alike. The Endocannabinoid System in Cannabis Cancer Treatment.

Treatment 75

Treatment Research and Development Cannabinoids THC 75

Veriheal

APRIL 7, 2022

Now, a new study has found that medical marijuana (MMJ) shows promise as a treatment for MS. . As with many other conditions, there is a lack of research regarding the use of MMJ as an alternative treatment to relieve symptoms of MS. . The Need for Better MS Treatment. The Need for Better MS Treatment.

Patients 98

Patients Treatment Cannabinoids Pharmaceutical 98

Cannabis Law Report

SEPTEMBER 24, 2019

Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. Some parents, who have travelled to the Netherlands to buy cannabis medicines, feel the treatment will not help many children because it does not contain THC, which they argue has helped their children. ” Source BBC: [link].

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Veriheal

JANUARY 26, 2023

Most commonly, pharmaceutical medication is prescribed to regulate moods. However, pharmaceutical medications can have side effects, and they may take longer to work for many patients. Thus, this groundbreaking study laid the foundation for understanding how cannabinoids can support mental health.

Treatment 98

Treatment Cannabinoids Conditions Pharmaceutical 98

The Cannigma

FEBRUARY 1, 2023

Even if a cannabinoid has shown promise on one cancer line, that doesn’t mean it will work for all cancers – even if it’s within the same organ system. Advocate for the rescheduling of cannabis to improve access to cannabis for research purposes, and scientific funding for novel cannabinoid-based cancer therapies.

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

Puff Puff Post

DECEMBER 28, 2018

Influencing how information is processed and how nerve cells and synapses in the brain interact, the exact function related to autism is still not well understood, and no pharmaceuticals around yet can ‘fix’ autism. The Current Treatments for Autism. As it sits, only a few methods of treating autism are available.

Treatment 76

Treatment Oil CBD Therapy 76

Cannabis Law Report

AUGUST 12, 2022

– August 11, 2022) – MOTAGON, a pharmaceutical company based in Prague and specializing in medical cannabis, has secured a ground-breaking agreement with Europe’s biggest indoor cannabis producer and one of the first cannabis extracts and formulations producers PHCANN INTERNATIONAL. ”

Extraction 52

Extraction Pharmaceutical Patients THC 52

Project CBD

SEPTEMBER 12, 2023

He would undergo a dozen surgeries and consume a steady diet of prescription narcotics and other pharmaceuticals. According to a 2012 study by University of Bonn scientist Andras Bilkei-Gorzo: “On the cellular level, the cannabinoid system regulates the expression of brain-derived neurotrophic factor and neurogenesis.”

Chronic Pain 228

Chronic Pain Treatment Cannabinoids Research and Development 228

SpeedWeed

JUNE 15, 2021

The British cannabis pharmaceutical company takes home an award that demonstrates how important cannabis has been to the British economy for over 20 years—but also how much it so far has been reserved, as an industry, and as a drug, for the elite. GW Pharmaceuticals was just awarded a so-called “ Queen’s Prize for Innovation.” .

Pharmaceutical 40

Pharmaceutical Chronic Pain Epilepsy Patients 40

United Patients Group

FEBRUARY 7, 2023

The effects of cannabis are caused by cannabinoids, which are chemical compounds found in the resin glands on the leaves and buds of female marijuana plants. Cannabinoids can help with inflammation and pain relief in various ways. Cannabis contains two types of cannabinoids: phytocannabinoids and endocannabinoids.

Cannabinoids 115

Cannabinoids Chronic Pain Terpenes THC 115

Cannabis Law Report

DECEMBER 1, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, today announced that it will participate in two investor conferences during the month of December 2021. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Chronic Pain Therapy 52

Cannabis Law Report

JULY 26, 2021

SciSparc intends to evaluate the efficacy, safety and tolerability of its Proprietary Cannabinoid-Based Treatment- SCI-110. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. TEL AVIV, Israel , July 26, 2021 /PRNewswire/ — SciSparc Ltd.

Research and Development 105

Research and Development Supply Chain Pharmaceutical Treatment 105

MMJ Recs

APRIL 1, 2024

CBD, one of the many cannabinoids found in the cannabis plant, has been garnering attention for its promising effects on various health conditions. Studies have suggested that CBD may help manage chronic pain, reduce anxiety and depression, alleviate symptoms of epilepsy, and even aid in cancer treatment.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52